LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mild-to-Moderate Hypertriglyceridemia Leads to Acute Pancreatitis

By LabMedica International staff writers
Posted on 23 Nov 2016
Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Pancreatitis is very painful and it may lead to fatalities and until now, medical science has connected the risk of developing this illness to gallstone, a high intake of alcohol and very high concentrations of blood fats or triglycerides.

Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.

Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.

The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.

Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.

Related Links:
Copenhagen University Hospital

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more